| 2023 |
|
| Seznam cyklů EHK Klepněte na kód cyklu jehož vyhodnocení si chcete prohlédnout. |
List of EQA rounds Click a code of the round to access the evaluation. |
| Kód cyklu EHK Code of EQA round |
Datum Date |
Název programu EHK Name of EQA programme |
| ABR1/23 | 24.3.2023 | Parametry acidobazické rovnováhy Acid-base Status and Electrolytes |
| ABR2/23 | 28.7.2023 | |
| ABR3/23 | 24.11.2023 | |
| AIH1/23 | 10.3.2023 | Autoimunitní hepatopatie Autoimmune Liver Diseases |
| AIH2/23 | 20.10.2023 | |
| AIM1/23 | 20.3.2023 | Autoimunita Autoimmunity |
| AIM2/23 | 2.10.2023 | |
| AKS1/23 | 27.1.2023 | Analyty krevního séra Basic Clinical Chemistry - Serum |
| AKS2/23 | 7.4.2023 | |
| AKS3/23 | 28.7.2023 | |
| AKS4/23 | 13.10.2023 | |
| ALB1/23 | 7.4.2023 | Stanovení albuminu v moči Albumin in Urine |
| ALB2/23 | 13.10.2023 | |
| AM1/23 | 7.4.2023 | Analyty moče Basic Clinical Chemistry - Urine |
| AM2/23 | 13.10.2023 | |
| AP1/23 | 31.3.2023 | Antitrombotické přípravky Antithrombotic Agents |
| AP2/23 | 15.9.2023 | |
| APLA1/23 | 17.3.2023 | Antifosfolipidové protilátky Antiphospholipid Antibodies |
| APLA2/23 | 29.9.2023 | |
| AT1/23 | 17.4.2023 | Autoprotilátky u tyreopatií Autoantibodies in Thyroid Diseases |
| AT2/23 | 30.10.2023 | |
| BIL1/23 | 10.2.2023 | Bilirubin novorozenecký Bilirubin Neonatal |
| BIL2/23 | 25.8.2023 | |
| BM1/23 | 14.4.2023 | Kostní markery Bone Markers |
| BM2/23 | 27.10.2023 | |
| CC1/23 | 10.2.2023 | Cystatin C Cystatin C |
| CC2/23 | 25.8.2023 | |
| CD341/23 | 1.5.2023 | Stanovení populace buněk CD34+ Population of CD34+ Cells |
| CD342/23 | 30.10.2023 | |
| CRC1/23 | 1.5.2023 | Kolorektální karcinom Colorectal Carcinoma |
| CRC2/23 | 19.9.2023 | |
| CRP1/23 | 10.2.2023 | Stanovení CRP C-Reactive Protein |
| CRP2/23 | 19.5.2023 | |
| CRP3/23 | 25.8.2023 | |
| CRP4/23 | 1.12.2023 | |
| CRPP1/23 | 27.1.2023 | Stanovení CRP systémy POCT C-Reactive Protein POCT |
| CRPP2/23 | 3.3.2023 | |
| CRPP3/23 | 9.6.2023 | |
| CRPP4/23 | 8.9.2023 | |
| CRPP5/23 | 20.10.2023 | |
| CRPP6/23 | 8.12.2023 | |
| CSFB1/23 | 28.3.2023 | Biochemická analýza likvoru Cerebrospinal Fluid Analysis |
| CSFB2/23 | 27.11.2023 | |
| CSFC1/23 | 28.3.2023 | Cytologie likvoru Cerebrospinal Fluid Cytology |
| CSFC2/23 | 27.11.2023 | |
| CSFF1/23 | 28.3.2023 | Izoelektrická fokusace likvoru Isoelectric focusing of CSF |
| CSFF2/23 | 27.11.2023 | |
| CSFK1/23 | 28.3.2023 | Klinická analýza likvoru Cerebrospinal Fluid Diagnostics |
| CSFK2/23 | 27.11.2023 | |
| CSH1/23 | 29.9.2022 | Cytochemické barvení v hematologii (studie) Cytochemical Staining in Haematology (study) |
| DD1/23 | 31.3.2023 | D Dimery D Dimers |
| DD2/23 | 16.6.2023 | |
| DD3/23 | 15.9.2023 | |
| DD4/23 | 17.11.2023 | |
| DGP1/23 | 17.2.2023 | Analýza moče testovacími proužky Urine Strip Tests Analysis |
| DGP2/23 | 19.5.2023 | |
| DGP3/23 | 1.12.2023 | |
| DIF1/23 | 17.3.2023 | Hodnocení nátěru periferní krve Peripheral Blood Morphology Evaluation |
| DIF2/23 | 26.5.2023 | |
| DIF3/23 | 15.9.2023 | |
| DIF4/23 | 27.10.2023 | |
| E11/23 | 7.2.2023 | Endokrinologie 1 Hormones 1 |
| E12/23 | 2.5.2023 | |
| E13/23 | 25.7.2023 | |
| E14/23 | 9.10.2023 | |
| E21/23 | 7.2.2023 | Endokrinologie 2 Hormones 2 |
| E22/23 | 2.5.2023 | |
| E23/23 | 25.7.2023 | |
| E24/23 | 9.10.2023 | |
| FC1/23 | 3.3.2023 | Kalprotektin ve stolici Calprotectin in Stool |
| FC2/23 | 22.9.2023 | |
| FOB1/23 | 19.5.2023 | Okultní krvácení Faecal Occult Blood |
| FOB2/23 | 1.12.2023 | |
| GHP1/23 | 17.3.2023 | Glykovaný hemoglobin POCT Glycated Haemoglobin POCT |
| GHP2/23 | 20.10.2023 | |
| GLC1/23 | 25.4.2023 | Stanovení glukózy (včetně glukometrů) Glucose (including glucometers) |
| GLC2/23 | 7.11.2023 | |
| GP1/23 | 3.3.2023 | Gamapatie Detection of Monoclonal Components |
| GP2/23 | 22.9.2023 | |
| HCB1/23 | 5.5.2023 | Histologické a cytologické barvení Histological and Cytological Staining |
| HCB2/23 | 10.11.2023 | |
| HIL1/23 | 21.4.2023 | Sérové indexy Serum Indices |
| HIL2/23 | 3.11.2023 | |
| HKG1/23 | 31.3.2023 | Hemokoagulace Haemocoagulation Tests |
| HKG2/23 | 16.6.2023 | |
| HKG3/23 | 15.9.2023 | |
| HKG4/23 | 17.11.2023 | |
| HR1/23 | 24.2.2023 | Hormonální receptory Hormonal Receptors |
| HR2/23 | 8.9.2023 | |
| HS1/23 | 16.6.2023 | Hemokoagulace speciální Haemocoagulation Special |
| HS2/23 | 17.11.2023 | |
| IDDM1/23 | 10.3.2023 | Autoimunitní diabetes 1. typu Type 1 Autoimmune Diabetes |
| IDDM2/23 | 20.10.2023 | |
| IFT1/23 | 1.5.2023 | Imunofenotypizace Immunophenotypisation |
| IFT2/23 | 30.10.2023 | |
| IGIT1/23 | 13.3.2023 | Imunopatologie GIT Immunopathology of GIT |
| IGIT2/23 | 23.10.2023 | |
| IH1/23 | 10.3.2023 | Imunohematologie Blood Group Serology |
| IH2/23 | 2.6.2023 | |
| IH3/23 | 29.9.2023 | |
| IH4/23 | 17.11.2023 | |
| IHC1/23 | 24.2.2023 | Imunohistochemie - detekce HER-2/neu Immunohistochemistry - Detection of HER-2/neu |
| IHC2/23 | 8.9.2023 | |
| INRP1/23 | 3.3.2023 | Měření INR systémy POCT INR measurement on POCT |
| INRP2/23 | 9.6.2023 | |
| INRP3/23 | 8.9.2023 | |
| INRP4/23 | 20.10.2023 | |
| KD1/23 | 27.1.2023 | Glykovaný hemoglobin Glycated Haemoglobin |
| KD2/23 | 7.4.2023 | |
| KD3/23 | 28.7.2023 | |
| KD4/23 | 3.11.2023 | |
| KM1/23 | 10.2.2023 | Kardiální markery Cardiac Markers |
| KM2/23 | 25.8.2023 | |
| KO1/23 | 10.3.2023 | Krevní obraz Blood Count |
| KO2/23 | 31.3.2023 | |
| KO3/23 | 19.5.2023 | |
| KO4/23 | 23.6.2023 | |
| KO5/23 | 8.9.2023 | |
| KO6/23 | 22.9.2023 | |
| KO7/23 | 6.10.2023 | |
| KO8/23 | 20.10.2023 | |
| LMWH1/23 | 31.3.2023 | Nízkomolekulární heparin Low Molecular Weight Heparin |
| LMWH2/23 | 15.9.2023 | |
| MS1/23 | 17.2.2023 | Močový sediment Urinary Sediment Morphology |
| MS2/23 | 19.5.2023 | |
| MS3/23 | 1.12.2023 | |
| NF1/23 | 17.3.2023 | Nátěr periferní krve - fotografie Peripheral Blood Smears - Photos |
| NF2/23 | 15.9.2023 | |
| NKDF1/23 | 26.5.2023 | Nátěr kostní dřeně - fotografie Bone Marrow Aspirate Film |
| NKDF2/23 | 27.10.2023 | |
| PAT1/23 | 2.6.2023 | Přímý antiglobulinový test Direct Antiglobulin Test |
| PAT2/23 | 17.11.2023 | |
| PDL11/23 | 30.5.2023 | Programmed Death Ligand 1 Programmed Death Ligand 1 |
| PDL12/23 | 30.10.2023 | |
| PIG1/23 | 10.3.2023 | Podtřídy IgG IgG subclasses |
| PIG2/23 | 20.10.2023 | |
| PRO1/23 | 3.3.2023 | Proteiny v krevním séru Specific Proteins |
| PRO2/23 | 22.9.2023 | |
| RC1/23 | 16.6.2023 | Retikulocyty na analyzátoru Reticulocytes (Analyser) |
| RC2/23 | 17.11.2023 | |
| RET1/23 | 26.5.2023 | Retikulocyty mikroskopicky Reticulocytes (Microscopy) |
| RET2/23 | 27.10.2023 | |
| RF1/23 | 17.3.2023 | Diagnostika revmatoidní artritidy a ASLO Diagnostics of Rheumatoid Arthritis and ASLO |
| RF2/23 | 29.9.2023 | |
| RFA1/23 | 7.4.2023 | Rizikové faktory aterosklerózy Risk Factors for Atherosclerosis |
| RFA2/23 | 13.10.2023 | |
| SED1/23 | 31.3.2023 | Sedimentační rychlost erytrocytů Erythrocyte Sedimentation Rate |
| SED2/23 | 15.9.2023 | |
| T02/23 | 24.1.2022 | Měření parametrů retikulocytů (studie) Measurement of reticulocyte parameters (study) |
| T04/23 | 12.5.2022 | Specifické IgE (studie) Specific IgE (study) |
| T05/23 | 19.5.2022 | Krevní obraz - nové parametry (studie) Blood count - new parameters (study) |
| T06/23 | 16.6.2022 | Měření antitrombinu (studie) Antithrombin measurement (study) |
| T21/23 | 8.9.2022 | Krevní obraz a retikulocyty (studie) Blood Count and Reticulocytes (study) |
| T23/23 | 23.10.2022 | Protilátky IgG anti EM a anti tTG (studie) Antibodies IgG anti EM and anti tTG (study) |
| TDM1/23 | 28.4.2023 | Léky Therapeutic Drugs |
| TDM2/23 | 6.10.2023 | |
| TE1/23 | 7.3.2023 | Stanovení stopových prvků Trace Elements |
| TE2/23 | 25.9.2023 | |
| TIE1/23 | 3.3.2023 | Stanovení celkového IgE Allergy Control Scheme (Total IgE) |
| TIE2/23 | 22.9.2023 | |
| TM1/23 | 7.2.2023 | Tumorové markery Tumour Markers |
| TM2/23 | 2.5.2023 | |
| TM3/23 | 25.7.2023 | |
| TM4/23 | 9.10.2023 | |
| VIB1/23 | 5.5.2023 | Všeobecná imunohistochemie - barvení General Immunohistochemistry - Staining |
| VIB2/23 | 10.11.2023 | |
| VVV1/23 | 21.4.2023 | Diagnostika vrozených vývojových vad Maternal Diagnostic Screening (Triple Test) |
| VVV2/23 | 3.11.2023 |